Earnings Alerts

China Petroleum & Chemical (386) Earnings: Sinopec Shanghai Reports Improved 1H Results on Rising Oil Prices and Steady Market Demand

  • Company: Sinopec Shanghai
  • Period: Preliminary results for the first half (1H) of 2024
  • Net Income: Approximately 24.6 million yuan to 36.9 million yuan
  • Reason for Improvement:
    • Rising international oil prices
    • Steady recovery in market demand
  • Analyst Recommendations:
    • 3 Buys
    • 3 Holds
    • 1 Sell

A look at China Petroleum & Chemical Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth5
Resilience3
Momentum5
OVERALL SMART SCORE4.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Petroleum & Chemical Corporation, also known as Sinopec, is expected to have a positive long-term outlook based on its Smartkarma Smart Scores. With high scores across the board in Value, Dividend, Growth, and Momentum, the company demonstrates strong financial performance and potential for future returns. This indicates that China Petroleum & Chemical is well-positioned to generate value for investors while offering attractive dividend payouts. Additionally, its robust growth prospects and positive momentum further enhance its attractiveness as an investment opportunity.

Specializing in the production and trading of petroleum and petrochemical products, China Petroleum & Chemical Corporation is a key player in the industry. The company’s diverse product range including gasoline, diesel, jet fuel, synthetic fibers, and chemical fertilizers enables it to cater to various market segments within China. With a solid foundation in place and strong ratings in key areas, China Petroleum & Chemical is poised for sustained growth and resilience in the dynamic energy sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars